The utility of whole-body positron emission tomography (PET) with 18-f-fluoro-deoxy-d-glucose (FDG) for diagnosis of recurrent gastric cancer

被引：0
|
作者：
De Potter, T [1 ]
Flamen, P [1 ]
Maes, A [1 ]
Van Cutsem, E [1 ]
Bormans, G [1 ]
Mortelmans, L [1 ]
机构：
[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2001年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OS212
引用
收藏
页码：1016 / 1016
页数：1
相关论文
共 50 条
  • [31] Clinical applications of F-18 fluoro-2-deoxy-D-glucose (FDG) positron emission tomography-computed tomography (PET/CT)
    Zanoni, Lucia
    Al-Sugair, Abdulaziz Saleh
    Fanti, Stefano
    NUCLEAR MEDICINE REVIEW, 2012, 15 : C48 - C51
  • [32] Value of positron emission tomography (18F-FDG-PET) in the diagnosis of recurrent rectal cancer
    Franke, J
    Rosenzweig, S
    Reinartz, P
    Höer, J
    Kasperk, R
    Schumpelick, V
    CHIRURG, 2000, 71 (01): : 80 - 85
  • [33] Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino, SL
    Fischman, MJ
    CHEST, 2004, 126 (03) : 755 - 760
  • [34] The role of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography (F18-FDG-PET) in the diagnosis of giant cell arteriitis of the temporal arteries
    Brodmann, M
    Passath, A
    Lipp, RW
    Stark, G
    Pabst, E
    Seinost, G
    Pilger, E
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 213 - 213
  • [35] The role of whole-body positron emission tomography with 18-fluorodeoxyglucose in recurrent gastric cancer.
    Chen, J
    Cheong, JH
    Yun, MJ
    Hyung, WJ
    Kim, J
    Choi, SH
    Noh, SH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [36] Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease
    Bangerter, M
    Moog, F
    Buchmann, I
    Kotzerke, J
    Griesshammer, M
    Hafner, M
    Elsner, K
    Frickhofen, N
    Reske, SN
    Bergmann, L
    ANNALS OF ONCOLOGY, 1998, 9 (10) : 1117 - 1122
  • [37] Clinical Impact of 2-Deoxy-2-[18F] fluoro-D-Glucose (FDG)-Positron Emission Tomography (PET) on Treatment Choice in Recurrent Cancer of the Cervix Uteri
    Bjurberg, Maria
    Brun, Eva
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (09) : 1642 - 1646
  • [38] The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer
    Schröder, W
    Zimny, M
    Rudlowski, C
    Büll, U
    Rath, W
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (02) : 117 - 122
  • [39] DIAGNOSIS OF PANCREATIC-CANCER BY 2[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY
    FRIESS, H
    LANGHANS, J
    EBERT, M
    BEGER, HG
    STOLLFUSS, J
    RESKE, SN
    BUCHLER, MW
    GUT, 1995, 36 (05) : 771 - 777
  • [40] Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
    Yoshio Yoshida
    Tetsuji Kurokawa
    Tetuya Tsujikawa
    Hidehiko Okazawa
    Fumikazu Kotsuji
    Journal of Ovarian Research, 2
12345